Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Invitae Corp
(NY:
NVTA
)
N/A
UNCHANGED
Last Price
Updated: 7:00 PM EST, Feb 5, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Headline News about Invitae Corp
< Previous
1
2
3
4
5
6
7
8
9
Next >
Cathie Wood Just Bought More Invitae (NVTA) Stock. Here’s Why.
May 05, 2022
Despite being down more than 60% year-to-date, Cathie Wood's Ark Invest remains confident in its thesis behind NVTA stock.
Via
InvestorPlace
Analyst Ratings for Invitae
May 04, 2022
Analysts have provided the following ratings for Invitae (NYSE:NVTA) within the last quarter:
Via
Benzinga
Recap: Invitae Q1 Earnings
May 03, 2022
Invitae (NYSE:NVTA) reported its Q1 earnings results on Tuesday, May 3, 2022 at 04:05 PM. Here's what investors need to know about the announcement. Earnings Invitae missed estimated earnings by 2.63%,...
Via
Benzinga
FDA Warns Against Relying On Screening Tests For Prenatal Diagnosis
April 20, 2022
The U.S. FDA is warning that noninvasive prenatal screening (NIPS) tests may provide false results, such as stating a fetus may have a genetic abnormality when the fetus was...
Via
Benzinga
Expert Ratings for Invitae
April 18, 2022
Over the past 3 months, 4 analysts have published their opinion on Invitae (NYSE:NVTA) stock. These analysts are typically employed by large Wall Street banks and tasked with understanding a company's...
Via
Benzinga
10 Health Care Stocks Whale Activity In Today's Session
March 18, 2022
This whale alert can help traders discover the next big trading opportunities. Whales are entities with large sums of money and we track their transactions here at Benzinga on our options activity...
Via
Benzinga
Stocks That Hit 52-Week Lows On Wednesday
February 23, 2022
On Wednesday, 348 companies hit new 52-week lows. Significant Points From Today's 52-Week Lows: The largest company by market cap to set a new 52-week low was...
Via
Benzinga
Stocks That Hit 52-Week Lows On Thursday
April 21, 2022
On Thursday, 236 companies hit new 52-week lows.
Via
Benzinga
Growth Stocks: Sell or Buy More?
March 17, 2022
Many companies IPO’d or came to the public market through a SPAC in the last 2 years. While other growth stocks have been around for years but had stretched valuations.
Via
Talk Markets
Will CPI Report Ruin The Biggest Stock Market Rally In 20 Months?
March 10, 2022
The S&P 500 had its biggest stock market rally since June 2020. Will the Consumer Price Index report coming out ruin the rally and reverse price lower?
Via
Talk Markets
Invitae Shares Fall As Q4 Earnings Fall Short Of Street Expectation
February 25, 2022
Invitae Corp's (NASDAQ: NVTA) Q4 FY21 revenues increased 26% Y/Y to $126.1 million, just shy of the consensus Wall Street estimate of $126.65 million. ...
Via
Benzinga
This Week's 5 Must-See Earnings Charts
February 24, 2022
There are a lot of recent, newly public companies that have put their earnings reports later in the earnings season. Many of them are popular with investors.
Via
Talk Markets
The Daily Biotech Pulse: Orphazyme Plunges On Regulatory Setback In Europe, Pulmonx Earnings Disappoint, Amicus Declines To Spin Off Genetic Medicine Company
February 24, 2022
Here's a roundup of top developments in the biotech space over the last 24 hours: Stocks In Focus Adagio Appoints COO David Hering As Interim CEO Adagio Therapeutics, Inc., (...
Via
Benzinga
The Week Ahead In Biotech (Feb. 20-26): Reata Awaits FDA Decision, Bausch Health, Moderna Lead Earnings News Flow
February 20, 2022
Biotech stock extended lower for a second straight week as risk aversion continued to pressure stocks amid geopolitical tensions and macroeconomic worries. On the regulatory front...
Via
Benzinga
Biotech Stocks Are Down And Out; Can These 2022 Trends Save Them?
February 17, 2022
Can the formerly red-hot biotech segment return to its previous glory?
Via
Investor's Business Daily
Stocks That Hit 52-Week Lows On Wednesday
January 05, 2022
Before 10 am on Wednesday, 99 companies set new 52-week lows. Facts of Interest About Today's 52-Week Lows: Sea (NYSE:SE) was the largest firm by market cap to set a...
Via
Benzinga
63 Biggest Movers From Friday
December 20, 2021
Gainers Spruce Biosciences, Inc. (NASDAQ: SPRB) jumped 102.8% to close at $5.03 on Friday after Oppenheimer initiated coverage on the stock with an Outperform rating and a $15...
Via
Benzinga
12 Health Care Stocks Moving In Friday's After-Market Session
December 10, 2021
Gainers Quoin Pharmaceuticals (NASDAQ:
Via
Benzinga
What Especially Stood Out From Invitae's Q3 Results
November 19, 2021
The big news from Invitae's Q3 update was a worsening bottom line.
Via
The Motley Fool
3 Stocks to Buy From Catastrophic Price Action
November 18, 2021
Even at all-time high index levels, there are stocks to buy. The brutal earnings dips are an opportunity to scoop up the strong outlooks.
Via
InvestorPlace
75 Biggest Movers From Yesterday
November 10, 2021
Find out what's going on in today's market and bring any questions you have to Benzinga's PreMarket Prep. Check out these big penny stock gainers and losers...
Via
Benzinga
58 Stocks Moving In Monday's Mid-Day Session
November 09, 2021
Gainers Dover Motorsports, Inc. (NYSE: DVD) shares climbed 60.3% to $3.59 after Speedway Motorsports announced it will acquire the company for $3.61 per share in cash. TDH...
Via
Benzinga
Why Are Invitae's Shares Plunging Today?
November 09, 2021
Invitae Corp's (NYSE: NVTA) Q3 sales increased 66% Y/Y to $114.4 million, missing the consensus Wall Street estimate of $126.55 million. Invitae posted an 89%...
Via
Benzinga
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
November 09, 2021
Gainers Compass Pathways (NASDAQ:CMPS) shares rose 18.43% to $51.0 during Tuesday's pre-market session. The company's market cap stands at $2.1 billion. As per the...
Via
Benzinga
The Daily Biotech Pulse: Double Dose Of Positive Tidings For Merck, Alkermes Slips On Partial Termination Of J&J Licensing Deal, Amgen Migraine Drug Data
November 09, 2021
Here's a roundup of top developments in the biotech space over the last 24 hours: Stocks In Focus Merck Gets Antitrust Nod For Acceleron Deal In Germany, Austria, Announces...
Via
Benzinga
32 Stocks Moving in Tuesday's Pre-Market Session
November 09, 2021
Gainers Dover Motorsports, Inc. (NYSE: DVD) rose 57% to $3.58 in pre-market trading. Luminar Technologies, Inc. (NASDAQ: LAZR) rose 54.2% to $26.98 in pre-market trading after...
Via
Benzinga
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Tuesday
November 09, 2021
Good morning! We're getting ready for another busy day of trading with a breakdown of the biggest pre-market stock movers for Tuesday!
Via
InvestorPlace
Invitae (NVTA) Q3 2021 Earnings Call Transcript
November 09, 2021
NVTA earnings call for the period ending September 30, 2021.
Via
The Motley Fool
Topics
Earnings
Exposures
Financial
The Week Ahead In Biotech (Nov. 7-Nov. 13): Earnings Taper Off, Multiple Conference Presentations, IPOs And More
November 08, 2021
Biotech stocks reversed course and closed the week ended Nov. 5 lower, squandering the gains notched early in the week. What was good news for Pfizer, Inc. (NYSE: PFE) turned out...
Via
Benzinga
Earnings Scheduled For November 8, 2021
November 08, 2021
Companies Reporting Before The Bell • Privia Health Group (NASDAQ:PRVA) is projected to report quarterly loss at $0.11 per share on revenue of $215.14 million. •...
Via
Benzinga
< Previous
1
2
3
4
5
6
7
8
9
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.